Please login to the form below

Not currently logged in
Email:
Password:

Merck acquires Amnis Corporation

Merck's Millipore division is to acquire Amnis Corporation, a US-based manufacturer of cell imaging systems

Merck Millipore, known as EMD Millipore in the US and Canada, is to acquire Amnis Corporation, a US-based manufacturer of cell imaging systems.

Merck Millipore is the life sciences division of German pharmaceutical firm Merck.

The transaction is expected to take place before the end of 2011 according to Amnis, with financial terms undisclosed.

Amnis had revenue of $14m (€10m) in 2010 developing, manufacturing and marketing tools for high speed cell imaging for research and diagnostic markets.

Jonathan DiVincenzo, head of the bioscience business unit within Merck Millipore said: "The acquisition of Amnis significantly contributes to our strategy to be a leader in cellular analysis and systems biology."

David A Basiji, co-founder and CEO of Amnis said: "The combination of Amnis with EMD Millipore will greatly accelerate development of novel applications in imaging flow cytometry, enhance our customer support, and accelerate product development."

30th August 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics